Patent ID: 11958862
Assignee: PGI DRUG DISCOVERY LLC
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 27:
28. The method according to claim 27, wherein the neurological or psychiatric disease or disorder is selected from paranoid schizophrenia, disorganized schizophrenia, catatonic schizophrenia, undifferentiated schizophrenia, schizoid personality disorder, schizotypal personality disorder, major depression, post-traumatic stress syndrome, semantic dementia, frontotemporal dementia, dementia with depressive features; persisting, subcortical dementia; dementia with Lewy Bodies, Parkinsonism-ALS Dementia Complex; dementia associated with Alzheimer's disease, ischemia, multi-infarct dementia, trauma, vascular problems, stroke, HIV disease, Parkinson's disease, Huntington's disease, Down syndrome, Pick's disease, Creutzfeldt-Jacob disease, perinatal hypoxia, or substance abuse; deficit in dopamine signaling, basal ganglia dysfunction, dysregulated locomotor activity, impairment of prefrontal cortex functioning, reactive attachment disorder, disinhibited social engagement disorder, obesity, bulimia nervosa, pica, compulsive eating disorders, bipolar I disorder, bipolar II disorder, cyclothymic disorder, substance/medication-induced bipolar and related disorders, bipolar and related disorder due to another medical condition, other specified bipolar and related disorder, unspecified bipolar and related disorders, autistic disorder, autism spectrum disorder, attention disorders, attention-deficit hyperactivity disorder (ADHD), benign forgetfulness, childhood learning disorders, specific learning disorders, intellectual development disorders, and closed head injury.